Trends of LMCA Revascularization
The ASAN MAIN registry was designed to investigate the real world outcomes of PCI and CABG for patients with significant ULMCA stenosis. The details of the design and the 5-year outcomes for the registry have been reported previously. 7 Significant ULMCA stenosis was defined as a visually estimated stenosis of >50% diameter. Patients who underwent concomitant valvular or aortic surgery, those who had an acute MI within 24 hours before revascularization, or those who presented with cardiogenic shock were excluded from this analysis. Target patients population was on either elective or urgent situation, but not on emergent situation. The Institutional Review Board of the Asan Medical Center approved the use of clinical data for this study, and all patients provided written informed consent for enrollment in the registry.
From January 1995 to May 2003, coronary stenting was performed exclusively with bare metal stents (BMS), whereas from May 2003 to December 2010, drug-eluting stents (DES) were used exclusively. Therefore, the patients were classified as BMS (wave 1, [1995] [1996] [1997] [1998] , early DES (wave 2, [2003] [2004] [2005] [2006] , and late DES (wave 3, [2007] [2008] [2009] [2010] .
Procedures
Patients underwent PCI instead of CABG because of either the patient's or physician's preference or because of the high risk associated with CABG. Methods of stent implantation for patients with ULMCA disease have been described previously. 2 All procedures were performed with standard interventional techniques. The use of predilation, intra-aortic balloon pumps, or intravascular ultrasound (IVUS), and the choice of the specific type of stents was at the operator's discretion. Antiplatelet therapy and periprocedural anticoagulation followed standard regimens. After the procedure, aspirin was continued indefinitely. Patients treated with BMS were prescribed ticlopidine (250 mg BID) for ≥1 month, and patients treated with DES were prescribed clopidogrel (75 mg QD) for ≥6 months, regardless of DES type. Treatment beyond this duration was at the discretion of the physician. Surgical revascularization was performed using standard bypass techniques. Complete revascularization was performed when possible with arterial conduits or saphenous vein grafts. Mainly, attempts were made to graft the left internal mammary artery to the left anterior descending artery. Onor off-pump surgery was performed at the surgeon's discretion. 8 
Clinical End Points and Follow-Up
The clinical outcomes of interest were death, the composite of allcause death, MI, and stroke, any repeat revascularization and the composite of death, MI, stroke and repeat revascularization (MACCE), post-PCI, or CABG. Deaths were considered cardiac unless an unequivocal, noncardiac cause was established. MI was defined as an increase in the creatine kinase myocardial band concentration to >5× the upper limit of the normal range and any of following: new pathological Q waves or new bundle branch block, angiographic documented new graft or new native coronary occlusion, or demonstration of new loss of viable myocardium or new regional wall motion abnormalities if occurring within 48 hours of the procedure, or any increase in creatine kinase myocardial band concentration to greater than the upper limit of the normal range, plus ischemic symptoms or signs if occurring >48 hours after the procedure. 9 Repeat revascularization included target vessel revascularization, regardless of whether the procedure was clinically or angiographically driven, and nontarget vessel revascularization. Stroke, as indicated by neurological deficits, was established by a neurologist on the basis of imaging studies. All outcomes of interest were carefully verified and adjudicated by independent clinicians.
Statistical Analysis
Clinical, angiographic, procedural, and operative data were summarized for the patient groups as numbers (percentages) for categorical variables and as median (interquartile range) for continuous variables. Differences in the parameters between the groups were compared using the Kruskal-Wallis test for continuous variables, and the χ 2 test for categorical variables.
Initially, we analyzed the trends of outcomes separately for PCI and CABG. We calculated the crude incidence rate per 100 person-year as follows: the crude incidence rate=number of cases/the summation of time spent in the study across all participants×100. Variables with a P value ≤0.20 in univariate analyses were candidates for multiple Cox proportional hazards regression model. A backward elimination process was used to develop the final multivariable models, using a threshold of 0.1 for variable elimination. Our independent variable, waves, was included as categorical variable with wave 3 as the reference in the final multivariable models. The results of the final models are provided in the Appendix in the Data Supplement. We multiplied the adjusted hazard ratio for each wave by the crude incidence rate to obtain riskadjusted incidence rates. We also evaluated waves as continuous variable to obtain adjusted hazard ratio for time trends. For the comparison between PCI and CABG according to the wave, we compared the each outcome between groups in similar ways as described above. Patients without experiencing events were censored at 2 years (720 days).
All reported P values were 2 sided, and a value of P<0.05 was considered statistically significant. SAS software, version 9.1 (SAS Institute, Inc, Cary, NC), was used for statistical analyses.
WHAT IS KNOWN
• Coronary artery bypass grafting has been considered standard care for patients with significant unprotected left main coronary artery stenosis.
• Recently among selected patients, percutaneous coronary intervention (PCI) has been considered as a potential alternative to coronary artery bypass grafting.
WHAT THE STUDY ADDS
• Comorbidities and the extent of coronary disease have become more complex in unprotected left main coronary artery patients undergoing either PCI or coronary artery bypass grafting over time.
• Nevertheless, rates of adverse events among patients treated with PCI have declined.
• The gap in treatment effect between PCI and coronary artery bypass grafting has decreased, and more patients are receiving PCI for the treatment for unprotected left main coronary artery stenosis. 
Results

Patient Characteristics
A total of 2618 patients with significant ULMCA stenosis were enrolled in the ASAN MAIN registry between January 1995 and December 2010. In the overall population, 1124 patients underwent PCI and 1494 patients underwent CABG. CABG was less frequently performed over time ( Figure 1 ). In wave 3, ≈52% of patients with significant ULMCA were treated by PCI.
Baseline characteristics of patients are shown in Table 1 . The mean age of all patients with ULMCA stenosis receiving revascularization increased over the study period from 62 (54-69) to 66 (58-72) years, and the proportions of patients with hypertension, diabetes mellitus, hyperlipidemia, and history of stroke also increased. The vascular extent and complexity of ULMCA stenosis increased over time, and mean ejection fraction decreased.
Revascularization Strategies
In patients receiving PCI, DES almost completely replaced BMS as the default stent platform over the period studied. The use of intravascular IVUS during PCI significantly increased. In wave 1, stents were mostly implanted in left main ostial or shaft lesions. More recently, bifurcation lesions were more frequently treated with a simple cross over technique than with 2-stent techniques. The number of stents per left main coronary artery and per patient also increased. In patients receiving CABG, the use of off-pump CABG increased. The total number of grafts decreased, but the use of the left internal mammary artery increased from 87% in wave 1 to 97% in wave 3 (Tables 2 and 3) . Medications prescribed at discharge also 
Outcomes
Unadjusted clinical outcomes are shown in Figure 2 . In patients receiving PCI, the incidence rates of death, the composite of death, MI, or stroke, repeat revascularization, and MACCE significantly decreased over the study period. However, in patients receiving CABG, the incidence rates of all clinical outcomes were unchanged, with the exception of the rate of repeat revascularization, which decreased over time. Table 5 shows risk-adjusted incidence rates (per 100 personyears). Similarly, in patients receiving PCI, the risk-adjusted incidence rates of death, the composite of death, MI, or stroke, repeat revascularization, and MACCE significantly decreased. In patients receiving CABG, the risk-adjusted incidence rates of death, the composite of death, MI, or stroke, and MACCE did not change, but the risk-adjusted incidence rate of repeat revascularization was significantly decreased.
The adjusted hazard ratio for MACCE of PCI compared with CABG significantly decreased over the period studied (Figure 3) . In wave 3, the adjusted hazard ratio for MACCE of PCI was not significantly different to that of CABG.
Discussion
This large study of patients with ULMCA stenosis demonstrates that during the past 16 years, clinical outcomes of patients receiving PCI for significant ULMCA stenosis have improved with respect to the safety and efficacy of the procedure although patient comorbidities and ULMCA stenosis complexity have worsened over time. Therefore, the gap in treatment effect between PCI and CABG has decreased and more patient received PCI for the treatment for ULMCA stenosis in recent years.
Until recently, PCI for ULMCA stenosis was performed to a limited extent in poor candidates for CABG. 10 In addition, data on elective PCI in the BMS or early DES eras are sparse. Therefore, systematic evaluations of changes or improvements to ULMCA revascularization strategies were not properly evaluated.
During the period studied here, substantial changes in patients' risk profiles were observed. Particularly, PCI and CABG were performed in significantly older patients in recent years. In addition, the proportion of patients with diabetes mellitus and hypertension has significantly increased. About the complexity of coronary artery disease, distal left main bifurcation involvement has become more frequent, and the extent of extra-LMCA disease has become more severe.
Despite the worsening of patient risk profiles and lesion complexity, a progressive decline in mortality, and other clinical adverse events, was observed over time in patients receiving PCI for significant ULMCA. These improved outcomes could be explained by the synergistic effects of the introduction of DES, a progressive increase in the use of IVUS during The introduction of DES could be a major contributing factor to the improvement of PCI outcomes. Although the LMCA itself seems to be relatively resistant to repeat stenosis because of its large caliber, PCI with BMS, particularly for distal left main bifurcation lesion or for the associated extra-LMCA disease shows a high event rate. 11, 12 In addition, in the critical left main position, a small or moderate degree of repeat stenosis could theoretically precipitate critical ischemia. A meta-analysis of observational studies and randomized controlled trials involving 10 342 patients with ULMCA stenosis demonstrated significantly lower crude mortality and adverse event rates in DES implanted patients than in BMS recipients, which is in accordance with the current study's observations. 12 In addition, the development and widespread use of secondgeneration DES, which is safer and more effective than first generation DES, could have further reduced adverse event rates in recent years. 13, 14 The increasing use of IVUS is another important factor. Angiographic evaluation of ULMCA stenosis has inherent limitations, but IVUS provides accurate information for stent sizing and helps to detect suboptimal stent deployment or stent-related complications, thereby making ULMCA PCI more effective and safer. In 1 clinical study, IVUS during ULMCA PCI reduced mortality, particularly in patients receiving DES, and some IVUS-defined parameters for left main stents was associated with a higher rate of mortality. 15 PCI strategy could determine prognosis, particularly for distal left main disease. In recent years, more patients with distal left main bifurcation stenosis received the single-stent crossover technique. In general, the single-stent crossover technique shows more favorable long-term clinical outcomes compared with the 2-stent technique, even in true bifurcation stenosis. 16, 17 The selection of a single-or 2-stent technique should be based on disease involvement and the supplying territory of the left circumflex ostium. IVUS provides accurate information for both main and side branch disease status and affects treatment strategy. Therefore, more frequent selection of the single-stent technique guided by the IVUS could further reduce adverse event rates over time.
The ASAN MAIN registry also shows that significant changes have occurred over time in revascularization strategies. The proportion of patients receiving PCI has progressively increased, and in recent years about half of patients with ULMCA stenosis received PCI. This trend has already been reported for patients with ULMCA stenosis presenting with acute coronary syndrome. 18 These findings extend it into the elective ULMCA PCI setting. These trends might be accelerating because of supportive data and updated practical guidelines.
In contrast to PCI, CABG did not show any decline in clinical events except repeat revascularization. This is not 19, 20 In addition, the outcomes of CABG are likely to be more sensitive to surgeons' technique than PCI. Comorbidities in patients receiving CABG have also worsened in recent years, which may be neutralizing the effects of the accumulation of experience and the improvement of operative or perioperative performance over time.
We conducted the evaluation of the comparative effectiveness between PCI and CABG according to the periods and showed the trend of the progressive decline in the gap of the treatment effect between 2 strategies over time, which was primarily because of the improved outcome of PCI. The lower mortality of patients receiving PCI than CABG in population of wave 3 was unexpected and was not easily explained. The difference in patient's characteristics and some medication including the lower prescription rate of statin and β-blocker in CABG group may affect the current results. However, this analysis was not random-comparison and thereby was not free from the selection bias of the observational study despite of . Adjusted hazard ratios were for CABG as compared with PCI. MACCE indicates major adverse cardiac or cerebral events; and RR, repeat revascularization. Trends of LMCA Revascularization the appropriate statistical adjustment. Therefore, these findings should be considered as the hypothesis generating and should be confirmed in large randomized controlled study. This study has the inherent limitations of single-center study. However, the ASAN MAIN registry has several advantages: its start date is January 1996, an early period for left main PCI, and it includes all consecutive patients receiving PCI, mostly in the elective setting. The population size and event numbers were statistically analyzable in each period. In addition, all ULMCA PCI procedures were performed by experienced operators. New techniques or technologies were adopted in a timely manner, and homogenously applied through consensus among operators. Therefore, the registry provides a valuable opportunity to evaluate trends in the practice and outcomes of ULMCA revascularization. In addition, high rate of IVUS use could be limited in the generalization of our findings.
In conclusion, the outcomes of LMCA PCI have significantly improved over time. In addition, more patients received PCI for LMCA stenosis in recent years.
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